Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease.
| Author | |
|---|---|
| Abstract |
:
We investigated whether a panel of 12 potential novel biomarkers consisting of proteins involved in synapse functioning and immunity would be able to distinguish patients with Alzheimer's disease (AD) and patients with mild cognitive impairment (MCI) from control subjects. |
| Year of Publication |
:
2018
|
| Journal |
:
Alzheimer's research & therapy
|
| Volume |
:
10
|
| Issue |
:
1
|
| Number of Pages |
:
5
|
| Date Published |
:
2018
|
| DOI |
:
10.1186/s13195-017-0335-x
|
| Short Title |
:
Alzheimers Res Ther
|
| Download citation |
